BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 53 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,286 | +2.7% | 16,661 | +6.6% | 0.00% | +50.0% |
| Q2 2023 | $635,375 | +97951.7% | 15,634 | +1.0% | 0.00% | -33.3% |
| Q1 2023 | $648 | -13.7% | 15,484 | -10.2% | 0.00% | -25.0% |
| Q4 2022 | $751 | -99.9% | 17,241 | -34.1% | 0.00% | -20.0% |
| Q3 2022 | $1,015,000 | +530.4% | 26,157 | +587.6% | 0.01% | +400.0% |
| Q2 2022 | $161,000 | -3.0% | 3,804 | +4.2% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -6.2% | 3,652 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $177,000 | +7.3% | 3,666 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $165,000 | -4.1% | 3,466 | -2.7% | 0.00% | 0.0% |
| Q2 2021 | $172,000 | +14.7% | 3,562 | +9.3% | 0.00% | 0.0% |
| Q1 2021 | $150,000 | -3.2% | 3,260 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $155,000 | +10.7% | 3,268 | -0.5% | 0.00% | 0.0% |
| Q3 2020 | $140,000 | +32.1% | 3,286 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $106,000 | +43.2% | 2,590 | +26.0% | 0.00% | 0.0% |
| Q1 2020 | $74,000 | – | 2,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 465,022 | $18,052,000 | 14.71% |
| Alterity Financial Group, LLC | 12,876 | $500,000 | 0.81% |
| PRIMORIS WEALTH ADVISORS, LLC | 8,232 | $325,000 | 0.58% |
| Cornerstone Advisory, LLC | 63,321 | $2,458,000 | 0.55% |
| Diversified, LLC | 15,863 | $616,000 | 0.31% |
| CORRADO ADVISORS, LLC | 9,285 | $360,000 | 0.29% |
| Founders Financial Alliance, LLC | 10,149 | $394,000 | 0.20% |
| Waterfront Wealth Inc. | 7,739 | $319,000 | 0.12% |
| Ford Financial Group, LLC | 7,200 | $279,000 | 0.12% |
| Eudaimonia Partners, LLC | 9,212 | $358,000 | 0.09% |